Virtus ETF Advisers’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Virtus ETF Advisers’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-254,541	Closed	-$433K	–	417
2018 Q3	$433K	Sell	254,541 -186,920	-42%	-$335K	0.04%	149
2018 Q2	$768K	Buy	+441,461	New	+$763K	0.68%	54
2017 Q4	–	Sell	-247,030	Closed	-$716K	–	291
2017 Q3	$716K	Hold	247,030	–	–	0.1%	71
2017 Q2	$1.1M	Buy	247,030 +185,922	+304%	+$767K	0.16%	51
2017 Q1	$285K	Buy	61,108 +5,858	+11%	+$34K	0.05%	143
2016 Q4	$336K	Sell	55,250 -13,004	-19%	-$68K	0.1%	105
2016 Q3	$376K	Hold	68,254	–	–	0.18%	83
2016 Q2	$259K	Buy	68,254 +24,913	+57%	+$84.4K	0.19%	82
2016 Q1	$120K	Sell	43,341 -2,702	-6%	-$9.79K	0.17%	139
2015 Q4	$261K	Buy	+46,043	New	+$281K	0.72%	60

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Virtus ETF Advisers's SGYP Position: Q4 2018 in Review

Virtus ETF Advisers sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 254,541 shares — an estimated $433K sold.

Virtus ETF Advisers first reported a position in SGYP in Q4 2015 and held it in 10 quarters. The position peaked at $1.1M in Q2 2017. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Virtus ETF Advisers reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Virtus ETF Advisers sold 254,541 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $433K.
Virtus ETF Advisers first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 10 quarters.
Virtus ETF Advisers's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.1M in Q2 2017.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Virtus ETF Advisers's 13F filing for Q4 2018, filed 5 Feb 2019.